TrialAmerican journal of clinical oncology2016

Treatment-related Hypertension as a Pharmacodynamic Biomarker for the Efficacy of Bevacizumab in Advanced Pancreas Cancer: A Pooled Analysis of 4 Prospective Trials of Gemcitabine-based Therapy With Bevacizumab.

Shubham Pant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.